Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
Open Access
- 16 September 2020
- journal article
- review article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (6), 3464-3472
- https://doi.org/10.1002/ehf2.12960
Abstract
People with cardiovascular disease (CVD) often contract coronavirus disease 2019 (COVID‐19). However, the interaction between COVID‐19 and CVD is unclear. In this systematic review, the available evidence for the crosstalk between COVID‐19 and CVD and its treatment was analysed. A search was performed in the electronic databases MEDLINE and EMBASE. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infects human cells via angiotensin‐converting enzyme 2. SARS‐CoV‐2 can cause CVD by inducing cytokine storms, creating an imbalance in the oxygen supply and demand and disrupting the renin–angiotensin–aldosterone system; SARS‐CoV‐2 infection can also lead to the development of CVD through the side effects of therapeutic drugs, psychological factors, and aggravation of underlying CVD. The most common CVDs caused by SARS‐CoV‐2 infection are acute myocardial injury, arrhythmia, and heart failure. Studies have found that there is an interaction between COVID‐19 and CVD. Underlying CVD is associated with a high risk of mortality in patients with COVID‐19. SARS‐CoV‐2 infection can also cause new‐onset CVD. Clinicians need to pay close attention to cardiovascular complications during the diagnosis and treatment of patients with COVID‐19 to reduce patient mortality.Keywords
Funding Information
- Zhejiang University
This publication has 76 references indexed in Scilit:
- Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RASJournal of Molecular and Cellular Cardiology, 2013
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- The ACE2 gene: its potential as a functional candidate for cardiovascular diseaseClinical Science, 2012
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysisBMJ, 2012
- Role of curcumin on chloroquine phosphate-induced reproductive toxicityDrug and Chemical Toxicology, 2011
- Cardiovascular complications of severe acute respiratory syndromePublished by Oxford University Press (OUP) ,2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- The Sympathetic Nervous System and HypertensionHypertension, 2004
- Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injuryCardiovascular Drugs and Therapy, 1989